Data / Drug companies / Acetaminophen and dextromethorphan hydrobromide
Acetaminophen and dextromethorphan hydrobromide: 6 companies and 9 products in the FDA NDC directory
Acetaminophen and dextromethorphan hydrobromide is listed in the FDA National Drug Code Directory by 6 companies, with 9 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are suspension; tablet, film coated; liquid, and the newest product started marketing on June 18, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 6
- Products
- 9
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 1
- Routes
- Oral
- Brand names
- Extra Strength Tylenol Cold Plus Flu Multi Symptom Day, Extra Strength Tylenol Severe Cough Plus Sore Throat Day, Childrens Tylenol Cold Plus Cough Plus Sore Throat, Daytime Cold and Flu, Delsym Cough Plus Sore Throat, Mucinex Childrens Mighty Chews Cold and Flu, Extra Strength Tylenol Severe Cough Plus Sore Throat Day, CVS Childrens Cold Plus Cough Plus Sore Throat
- openFDA record search
- api.fda.gov
Companies that list acetaminophen and dextromethorphan hydrobromide
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Kenvue Brands LLC | 4 | tablet, film coated; liquid | Over the counter monograph drugs | June 18, 2026 |
| CVS Woonsocket Prescription Center, Incorporated | 1 | suspension | Over the counter monograph drugs | February 1, 2023 |
| Humanwell PuraCap Pharmaceutical (Wuhan), Ltd. | 1 | capsule, liquid filled | Over the counter monograph drugs | December 28, 2025 |
| Reckitt Benckiser LLC | 1 | solution | Over the counter monograph drugs | July 1, 2019 |
| Reckitt Benckiser LLC | 1 | tablet, chewable | Over the counter monograph drugs | June 1, 2025 |
| Walgreen Company | 1 | suspension | Over the counter monograph drugs | February 24, 2023 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Suspension | 3 | 33.3% |
| Tablet, film coated | 2 | 22.2% |
| Liquid | 1 | 11.1% |
| Capsule, liquid filled | 1 | 11.1% |
| Solution | 1 | 11.1% |
| Tablet, chewable | 1 | 11.1% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 9 | 100% |
Pharmacologic classes
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.